The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia

• Linda J. Bristow ,

  * E-mail: Linda.bristow@bms.com

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Amy E. Easton,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Yu-Wen Li,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Digavalli V. Sivarao,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Regina Lidge,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Kelli M. Jones,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Debra Post-Munson,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Christopher Daly,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Nicholas J. Lodge,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Lizbeth Gallagher,

  Affiliation Lead Discovery and Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Thaddeus Molski,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Richard Pieschl,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Ping Chen,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Adam Hendricson,

  Affiliation Lead Discovery and Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Ryan Westphal,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• James Cook,

  Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Christiana Iwuagwu,

  Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Daniel Morgan,

  Affiliation Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Yulia Benitex,

  Affiliation Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Dalton King,

  Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• John E. Macor,

  Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• Robert Zaczek,

  Affiliation Discovery Biology, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
•  [ ... ],
• Richard Olson

  Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Wallingford, Connecticut, United States of America

  ⨯
• [ view all ]
• [ view less ]